Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-02-19

FDA Approved: GEMFIBROZIL — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for Gemfibrozil filed by Chartwell RX, LLC under an existing ANDA, indicating regulatory approval related to the generic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemfibrozil (Gemfibrozil)

Snippet

SUPPL AP for GEMFIBROZIL (GEMFIBROZIL)